Programs

HomePrograms ▶ Partner Grants
Partner Grants

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
Letters of Intent (LOI) are available on the Foundant Technologies Website.
You must be invited to submit a full application.


Anticipated Timeline

July 20, 2021 Letter of Intent Period Opens
September 14, 2021 Deadline for Letter of Intent due by 11:59 pm Eastern Time
December 1, 2021 Invitation from Scientific Advisory Committee for Full Applications
January 11, 2022 Full Application Deadline due by 11:59 pm Eastern Time
March 2022 Grantee Notification
April/May 2022 Grant Start Date

 
Current Partner Grant Opportunities

Alpha-1 Foundation

ATS/Alpha-1 Foundation Research Grant
1 grant available
$40,000 per year for 2 years

Target Audience:
Investigators (junior or established) interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1)

The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Applicants must not be current awardees of the Alpha-1 Foundation Research Program 
• Must meet eligibility requirements for all grants found here

Co-funded by the ATS and the Alpha-1 Foundation.

American Lung AssociationCHEST Foundation
ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award
2 grants available
$100,000 per year for 2 years

Target Audience:
  • The first award is intended to support investigators that will address topics on improving clinical outcomes in preventing and/or treating lung disease in groups disproportionately impacted.

  • The second award is intended to support an investigator who is a person of color that is doing clinical research in a pulmonary disease that disproportionately affects communities of color. 

The focus of these research grants is clinical research that addresses topics on improving clinical outcomes in preventing and/or treating lung disease that disproportionately affects under-represented minority (URM) patient groups. URM patient groups includes patients from lower-middle- and low-income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans.  

Applicants may request up to $100,000 per year for two years for salaries, supplies, or a combination of these two. No more than 20% of the budget can be for salary. Indirect costs will not be paid to the sponsoring institution.

Recipients will also be eligible for complimentary registration and a $1,000 travel stipend to attend both the ATS International Conference and CHEST Annual Meeting up to one year past conclusion of the research to present data.

Award-specific eligibility: 
  • Must be US citizens or hold a Visa that spans the project period of the grant
  • Junior investigators (as defined here)and applicants who are trainees (fellows)
  • Applicants holding PhD, MD, RN, RRT, or PA degrees
  • Must be a member of the ATS and CHEST
  • Must meet eligibility requirements for all grants found here
Co-funded by the American Lung Association, ATS, and the CHEST Foundation.

 
copd-logos_copdf-logo-one-line.png

ATS/COPD Foundation Research Grant
1 grant available
$40,000 per year for 2 years

Target Audience:
Investigators interested in research that is relevant to non-CF Bronchiectasis

The focus of this research grant is proposals that have a high likelihood to advance the understanding of the pathophysiology of non-CF Bronchiectasis. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution

Award-specific eligibility: 
• Junior investigators (as defined here) or established investigators at any stage in their career
• Must meet eligibility requirements for all grants found here 
 
Co-funded by the ATS and the COPD FoundationPlease visit bronchiectasisandntminitiative.org for more information about our partner.

  
gsk-shield-logo.jpg

ATS/Foundation for Sarcoidosis Research Grant
1 grant available
$25,000 per year for 2 years

Target Audience:
Eary career investigators interested in research that is relevant to sarcoidosis

The focus of this research grant is proposals that advance research in the area of sarcoidosis. Applicants may request up to $25,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution. 

Award-specific eligibility: 
• Junior investigators (as defined here) 
• Must meet eligibility requirements for all grants found here

Co-funded by the ATS and the Foundation for Sarcoidosis Research.


Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Grant Review Committee (SGRC)* will review the applications at the end of February/beginning of March 2022. The membership of the SGRC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.

*previously known as the Scientific Advisory Committee (SAC)


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SGRC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.

 

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.